| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 698,027 | 849,305 | 791,611 | | Cost of Revenue | 643,008 | 710,050 | 647,152 | | | Gross Profit | 55,019 | 139,255 | 144,459 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 22,519 | 101,190 | 104,228 | | Non Recurring | 4,644 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 27,856 | 38,065 | 40,231 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 27,856 | 38,065 | 40,231 | | Interest Expense | 5,808 | 8,123 | 10,125 | | Income Before Tax | 22,048 | 29,942 | 30,106 | | Income Tax Expense | 9,219 | 13,582 | 12,729 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,829 | 16,360 | 17,377 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 12,829 | 16,360 | 17,377 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,829 | $16,360 | $17,377 |
|
0.29% Nasdaq 
Income Statement
